BioCentury
ARTICLE | Finance

Curating Abingworth

How Abingworth has curated its strategy to strengthen its latest fund

July 13, 2018 6:49 PM UTC

With a narrower set of investment strategies and a diversified LP base for its latest fund, Abingworth is seeking double digit returns from the $315 million Bioventures VII.

Abingworth’s Kurt von Emster told BioCentury the fund, which closed on July 9, is slated to make about 16 investments, spread among early stage venture rounds, clinical co-development deals and venture investments in private equities (VIPES). ...